Profile data is unavailable for this security.
About the company
Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
- Revenue in EUR (TTM)17.98bn
- Net income in EUR238.00m
- Incorporated2000
- Employees67.25k
- LocationRoyal PhilipsHigh Tech Campus 5EINDHOVEN 5656 AENetherlandsNLD
- Phone+31 205977777
- Websitehttps://www.philips.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Smith & Nephew plc | 4.97bn | 352.21m | 11.76bn | 17.35k | 33.37 | 2.61 | 13.01 | 2.37 | 0.3466 | 0.3466 | 4.89 | 4.44 | 0.5713 | 0.7378 | 4.33 | 246,733.30 | 4.05 | 3.62 | 4.98 | 4.41 | 69.64 | 70.47 | 7.09 | 7.10 | 1.33 | 6.42 | 0.3868 | 87.54 | 4.70 | 2.49 | 56.65 | -7.24 | -1.36 | -2.01 |
| BioMerieux SA | 3.98bn | 432.20m | 14.39bn | 14.75k | 33.42 | 3.41 | 19.18 | 3.62 | 3.64 | 3.64 | 33.51 | 35.66 | 0.7217 | 1.81 | 5.23 | 269,750.60 | 7.71 | 9.22 | 9.66 | 11.94 | 55.66 | 56.58 | 10.68 | 12.35 | 1.29 | 29.74 | 0.1044 | 20.24 | 8.31 | 8.27 | 20.86 | 9.64 | 4.88 | 36.49 |
| Sonova Holding AG | 4.14bn | 579.53m | 15.13bn | 17.99k | 26.17 | 5.29 | 17.74 | 3.65 | 9.04 | 9.04 | 64.66 | 44.70 | 0.6599 | 2.36 | 6.93 | 214,863.80 | 9.34 | 10.74 | 12.11 | 13.66 | 72.43 | 72.16 | 14.15 | 17.50 | 0.9618 | 18.80 | 0.3514 | 42.61 | 6.58 | 5.79 | -10.07 | 5.22 | 1.33 | -- |
| Sartorius AG | 3.44bn | 95.50m | 15.28bn | 13.57k | 131.10 | 4.64 | 26.35 | 4.44 | 1.39 | 1.39 | 50.31 | 39.25 | 0.3321 | 2.08 | 9.50 | 254,590.50 | 1.51 | 6.19 | 2.00 | 8.65 | 45.27 | 49.69 | 4.54 | 12.35 | 0.9259 | 2.83 | 0.5468 | 22.30 | -0.4417 | 13.10 | -59.14 | -11.72 | 12.69 | 15.84 |
| Coloplast A/S | 3.73bn | 609.03m | 17.35bn | 16.74k | 30.52 | 8.19 | 22.02 | 4.66 | 20.17 | 20.17 | 123.39 | 75.18 | 0.5714 | 2.45 | 5.92 | 1,710,716.00 | 9.34 | 16.21 | 13.17 | 22.91 | 67.52 | 67.85 | 16.35 | 21.02 | 0.6082 | 8.87 | 0.5889 | 92.23 | 10.33 | 8.54 | 5.62 | 5.46 | 14.30 | 5.29 |
| Straumann Holding AG | 2.68bn | 490.68m | 18.44bn | 11.82k | 37.60 | 8.43 | 28.45 | 6.87 | 2.87 | 2.43 | 15.69 | 12.79 | 0.7215 | 1.79 | 4.28 | 211,925.50 | 13.24 | 12.06 | 17.41 | 15.54 | 71.40 | 74.11 | 18.35 | 17.39 | 1.15 | 15.33 | 0.1871 | 32.23 | 9.98 | 9.42 | 2.11 | 8.35 | 2.28 | 10.56 |
| Sartorius Stedim Biotech SA | 2.86bn | 204.30m | 20.02bn | 9.96k | 97.52 | 5.04 | 38.85 | 7.01 | 2.11 | 2.11 | 29.48 | 40.83 | 0.3414 | 2.06 | 9.53 | 288,627.40 | 2.47 | 8.62 | 2.80 | 10.54 | 43.89 | 49.34 | 7.23 | 15.34 | 1.14 | 3.53 | 0.4226 | 20.94 | 0.1621 | 14.05 | -43.57 | -5.67 | 20.10 | 15.21 |
| Koninklijke Philips NV | 17.98bn | 238.00m | 20.39bn | 67.25k | 84.66 | 1.67 | 14.50 | 1.13 | 0.25 | 0.3934 | 19.22 | 12.64 | -- | -- | -- | 265,101.80 | -- | -0.8858 | -- | -1.21 | 43.42 | 44.38 | 1.31 | -1.47 | 0.7901 | 4.31 | 0.3922 | -- | -0.8146 | 0.9993 | -85.09 | -- | -6.60 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Artisan Partners LPas of 28 Jun 2024 | 94.13m | 10.01% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 28.69m | 3.05% |
| Edgepoint Investment Group, Inc.as of 31 Dec 2024 | 26.56m | 2.83% |
| Mondrian Investment Partners Ltd.as of 13 May 2024 | 25.77m | 2.74% |
| UBS Asset Management (UK) Ltd.as of 01 Mar 2024 | 23.11m | 2.46% |
| Norges Bank Investment Managementas of 31 Dec 2024 | 17.05m | 1.81% |
| BlackRock Fund Advisorsas of 03 Jul 2025 | 15.66m | 1.67% |
| T. Rowe Price International Ltd.as of 02 Jul 2025 | 14.62m | 1.56% |
| Causeway Capital Management LLCas of 31 May 2025 | 13.74m | 1.46% |
| Pzena Investment Management LLCas of 31 Mar 2025 | 10.26m | 1.09% |
